Atlas Trials

Efficacy Evaluation of a Commercial Preparation Containing Lactobacillus Casei DG on the Reduction of the Painful Symptoms Related to the Irritable Bowel Syndrome (IBS). A Pilot Clinical Study

Clinical trial NCT02077699 · COMPLETED

Trial details

NCT number
NCT02077699
Sponsor
SOFAR S.p.A.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Irritable Bowel Syndrome
Start date
2012-03-01
Primary completion
2014-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.